Skip to Content

Fluenz

Active Substance: Reassortant influenza virus (live attenuated) of the following strains: A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
Common Name: influenza vaccine (intranasal, live attenuated)
ATC Code: J07BB03
Marketing Authorisation Holder: MedImmune LLC
Active Substance: Reassortant influenza virus (live attenuated) of the following strains: A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
Status: Withdrawn
Authorisation Date: 2011-01-27
Therapeutic Area: Influenza, Human Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

Prophylaxis of influenza in individuals 24 months to less than 18 years of age.

The use of Fluenz should be based on official recommendations.

The marketing authorisation for Fluenz has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide